We recently compiled a list of the 10 High Growth Pharma Stocks That Are Profitable in 2025. Merck & Co., Inc. stands third among them. Merck & Co., Inc. (NYSE:MRK), a global leader in pharmaceuticals ...

Coupled with headwinds in China, Merck is also seeing lower demand for Gardasil in Japan. Sales are expected to remain weak in Japan in the second half of 2025. Our estimates for Gardasil sales ...

ACOG released updated clinical guidance on vaccination for COVID-19, respiratory syncytial virus and influenza during ...

Pfizer is a solid dividend stock. Its forward yield currently tops 7%, and the company has increased its payouts by 19.5% in ...

Oncologists and scientists warn that extensive cuts to mRNA funding will have devastating impacts on cancer vaccine ...

The American College of Cardiologists recommends people with heart disease get their COVID-19 and flu shots, breaking with CDC guidelines.

The health and human services secretary, Robert F. Kennedy Jr., is accusing the American Academy of Pediatrics of a ...

As biotech is making a push to protect cattle from the screwworm, delve into the broader field of livestock-specific biotech.

The shot, called clesrovimab and given the brand name Enflonsia, is made by Merck and joins two other interventions already on the market to protect babies against severe disease from RSV, a ...

For our part, Moderna has joined our watchlist of discarded, beaten-up, and unloved firms. In the quarters and years ahead, ...

Real-world study data showed that the monoclonal antibody nirsevimab was highly effective at preventing severe respiratory ...

The global Vaccines Market, valued at US$59.52 billion in 2024, stood at US$50.46 billion in 2025 and is projected to advance at a ...